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Abstract
Effective treatment of infections caused by the bacterium Staphylococcus aureus remains a worldwide challenge, in part due
to the constant emergence of new strains that are resistant to antibiotics. The serine/threonine kinase PknB is of particular
relevance to the life cycle of S. aureus as it is involved in the regulation of purine biosynthesis, autolysis, and other central
metabolic processes of the bacterium. We have determined the crystal structure of the kinase domain of PknB in complex
with a non-hydrolyzable analog of the substrate ATP at 3.0 A ˚ resolution. Although the purified PknB kinase is active in
solution, it crystallized in an inactive, autoinhibited state. Comparison with other bacterial kinases provides insights into the
determinants of catalysis, interactions of PknB with ligands, and the pathway of activation.
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Introduction
The gram-positive bacterium Staphylococcus aureus is a serious
human pathogen that is responsible for an increasing number of
illnesses and deaths each year [1]. The bacterium colonizes the
nose and skin of humans and can cause illnesses ranging from skin
infections [2] to life-threatening diseases such as endocarditis,
bacteremia, pneumonia, meningitis, osteomyelitis, sepsis and the
toxic shock syndrome [3,4,5,6]. Successful treatment of S. aureus
infections remains a challenge as drug-resistant strains, such as
methicillin-resistant and vancomycin-resistant S. aureus (MRSA
and VRSA, respectively), are gaining prominence. Furthermore,
the emergence of community-acquired S. aureus strains forms
a rapidly emerging public health problem [7]. In order to develop
new strategies to combat these bacteria, a better understanding of
the organisms and the functions of its components is needed.
To overcome stressful conditions imposed by its host, S. aureus
has developed various protective and offensive responses such as
the sensing of environmental stimuli and the activation and
inactivation of response regulators. This is generally achieved
through cascades of phosphorylation reactions in the host, which
in turn points to a key role of protein kinases in staphylococcal
persistence. Protein kinases regulate a multitude of processes and
signal transduction pathways in prokaryotes and eukaryotes [8]. A
subgroup, the serine/threonine kinases (STKs), was originally
thought to only be present in eukaryotic cells. However, in recent
years STKs have also been identified in bacteria [9,10], and these
have been classified as eukaryotic-type serine/threonine kinases
[11]. While many microorganisms encode for several eukaryotic-
type STKs, S. aureus encodes only for one such protein, which has
been termed PknB, PrkC or Stk1 by different research groups
[11,12,13] and will be referred to as PknB here. PknB was
originally identified through a transposon mutagenesis approach
and is conserved in all S. aureus strains [14]. The kinase is
composed of an N-terminal, cytosolic kinase domain, a central
transmembrane domain, and three C-terminal, extracellular
PASTA (penicillin-binding protein and serine/threonine kinase
associated) domains (Fig. 1). PASTA domains are constructed
from about 65–70 amino acids and are thought to bind beta-
lactam compounds as well as peptidoglycans [15,16]. The number
of PASTA domains present in eukaryotic-type STKs can vary. S.
aureus PknB and B. subtilis PrkC have both three PASTA domains,
while the PknB of M. tuberculosis contains four such repeats
[11,12,17].
PknB is of particular relevance for S. aureus survival and
pathogenesis as it helps to regulate purine biosynthesis, autolysis,
and other central metabolic processes of the bacterium and is
involved in antibiotic resistance [12,18,19]. Moreover, recent data
show that PknB can also act on human cellular proteins, and that
these potential targets are involved in apoptosis, immune
responses, transport, and metabolism [20]. The recently discov-
ered secretion of PknB may also help the bacterium to evade
intracellular killing and facilitate its growth [20]. Proper function
of PknB is important for full expression of S. aureus pathogenesis,
and it is also likely that phosphorylation levels controlled by PknB
are essential in controlling bacterial survival within the host [21].
Structural information on S. aureus PknB is so far limited to the
three PASTA domains that constitute the extracellular portion of
the protein [11,17]. Structural analyses of PknB homologs, such as
PknB from M. tuberculosis [22,23,24,25,26] have provided insights
into the overall fold of the cytosolic kinase domain and its
interactions with ligands. However, it is well established that
kinases adopt similar folds but differ in subtle ways in order to
achieve their specificity. Here, we report a structural analysis of
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cleavable ATP analog, adenosine 59-(b, c-imido)-triphosphate
(AMP-PNP). Comparison with other bacterial STKs provides
insights into the determinants of PknB catalysis, its state of
activation, and its interactions with potential ligands.
Materials and Methods
Cloning, expression and purification
DNA encoding the kinase domain of S. aureus PknB (PknBSA-KD)
(residues 1–291) of S. aureus strain 8352 (GenBank accession
number BAB42315) was amplified by PCR, and NdeI and XhoI
cleavage sites and an additional stop codon were introduced. After
digestion with NdeI and XhoI, the PCR product was inserted into
the pET28b vector (Novagen), which includes an N-terminal His6-
tag followed by a thrombin cleavage site, for protein expression in
E. coli strain BL21-DE3. Transformed bacteria were grown in LB
medium supplemented with 30 mg/ml kanamycin at 37uCt oa n
optical density of 0.3 at 600 nm. After lowering the temperature to
20uC, the bacteria were induced by addition of 1 mM isopropyl-b-
thiogalactopyranoside. After 24 hours of expression, bacteria were
harvested by centrifugation and resuspended in 20 mM HEPES,
150 mM NaCl, 20 mM imidazole and 1 mM phenylmethanesul-
fonyl fluoride at pH 7.4. The sonified lysate was clarified by
centrifugation and filtered. The solution was loaded onto a Hi-
sTrap column (GE Healthcare), which was then washed with lysis
buffer. The His-tagged PknBSA-KD was eluted with a linear
imidazole gradient ranging from 10 to 500 mM. After reducing
the imidazole concentration by alternating concentration and
dilution steps, the protein was cleaved with thrombin (1 U/mg
protein; GE Healthcare) for 24 h at 20uC. Cleavage was followed
with a second Ni
2+-affinity run to remove thrombin and uncleaved
PknBSA-KD. The 33.1 kDa PknBSA-KD was concentrated and
purified by gel filtration (Superdex 75, GE Healthcare) in 20 mM
HEPES, 150 mM NaCl at pH 7.4 (Fig. S1A). SDS-PAGE
confirmed the purity of the product (Fig. S1B). Mass spectrometry
analysis was used to verify the identity of PknBSA-KD, and circular
dichroism spectroscopy (CD-spectroscopy, Jasco J -720) confirmed
that it was folded (Fig. S1C). PknBSA-KD was used at a concentra-
tion of 0.2 mg/mL in 2.5 mM HEPES, 18.75 mM NaCl at
pH 7.4 for CD-spectroscopy measurements at room temperature.
Figure 1. Domain structure of S. aureus PknB. The kinase region (PknBSA-KD) is shown in orange. TM: transmembrane domain, PASTA: penicillin-
binding protein and serine/threonine kinase associated domains.
doi:10.1371/journal.pone.0039136.g001
Table 1. Data collection and refinement statistics.
Parameter Value
Data collection
Beam line X06SA, SLS
Wavelength (A ˚) 1.0000
Space group C2
Cell dimensions
a, b, c (A ˚) 221.51, 127.55, 70.28
a, b, c (u) 90.00, 89.96, 90.00
Resolution (A ˚) 45.0–3.0 (3.08–3.00)
a
Rmeas 4.8 (46.0)
a
I/sI 17.99 (2.68)
a
Completeness (%) 99.1 (99.5)
a
Unique reflections 38,868 (2,889)
a
Redundancy 3.39 (3.38)
a
Wilson B (A ˚2) 95.43
Refinement
Resolution (A ˚) 43.5–3.0
Rwork/Rfree 0.2149/0.2464 (0.3403/0.3962)
a
No. of atoms 12,609
Protein 12,420
Ligands 189
B-factors (A ˚2)
Protein 97.1
Benzamidine/AMP-PNP 87.9/105.1
r.m.s.
b deviations
Bond lengths (A ˚) 0.005
Bond angles (u) 0.918
Ramachandran plot
Most favored regions (%) 95.7
Allowed regions (%) 4.3
Disallowed regions (%) 0.0
aValues in parentheses are for highest resolution shell.
br.m.s., root mean square.
doi:10.1371/journal.pone.0039136.t001
Figure 2. Activity test of PknBSA-KD. PknBSA-KD (25 ng) was
incubated either with myelin basic protein (MBP; 1 mg) (A) or alone
(B) together with c
33-ATP, MnCl2 and MgCl2 for the time indicated.
Position and size (kDa) of molecular weight markers are indicated on
the left side. Phosphorylation of MBP (A) and autophosphorylation (B)
are visualized by autoradiography using direct-exposure film. The
phosphorylation rate is increasing as a function of time in both
experiments, demonstrating that the purified PknBSA-KD protein is
active.
doi:10.1371/journal.pone.0039136.g002
Structure of S. aureus PknB
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speed 100 nm/min with a data pitch of 0.5 nm.
Chemical cross-linking
Purified PknBSA-KD was incubated with different concentrations
of glutaraldehyde for 15 min at room temperature. The reaction
was stopped by adding 4xSDS-protein buffer and incubating the
mixture at 95uC for 5 minutes. Identical procedures were carried
out with the 22 kDa adenovirus type 21 fiber knob (Ad21), which
forms trimers and served as a positive control, and with the 25kDa
chymotrypsinogen A (Sigma-Aldrich), which is monomeric and
served as the negative control.
Protein kinase assay
In vitro phosphorylation of 25 mg/mL PknBSA-KD was per-
formed for the indicated time at 37uC with 1 mg/mL myelin basic
protein (MBP, Sigma, Deisenhofen, Germany) and 4 mCi c
33-
ATP/mli n2 0 ml reaction buffer containing 50 mM HEPES
(pH 7.5), 1 mM DTT, 0.01% Brij35, 3 mM MnCl2 and 3 mM
MgCl2. In each case, the reaction was stopped by adding 4xSDS-
protein buffer. One-dimensional gel electrophoresis was per-
formed and finally, radioactive proteins were visualized by
autoradiography using direct-exposure film.
Protein crystallization and structure determination
The final solution used for crystallization contained 8 mg/mL
PknBSA-KD, 5 mM MgCl2, 4 mM AMP-PNP (tetralithium salt
hydrate), 2% (w/v) benzamidine hydrochloride and 1 mM
dithiothreitol in 20 mM HEPES, 150 mM NaCl at pH 7.4.
Crystals were grown with the sitting drop vapor diffusion method
by mixing equal amounts of protein solution and crystallization
solution (80 mM 2-(N-morpholino)ethanesulfonic acid pH 6.0, 1.3
M sodium citrate (pH 7.0), 2% (w/v) benzamidine hydrochloride
and 60 mM MgCl2 at 4uC. Crystals appeared after several days
and grew to a maximum size of 150 mm diameter. Crystallization
trials using mixtures of MnCl2 and MgCl2 or MnCl2 could not
improve the crystal quality. They belong to space group C2 and
contain six kinase domains in their asymmetric unit. The crystals
were mounted on a loop and flash frozen in liquid nitrogen prior
to data collection.
X-ray diffraction experiments were performed at the X06SA
beam line of the Swiss Light Source, Paul Scherrer Institut,
Villigen, Switzerland. Data extending to 3.0 A ˚ resolution were
recorded using the PILATUS detector and processed with XDS
[27]. Initial phases were determined with PHASER [28] using the
M. tuberculosis PknB structure as search model (Protein data bank
(PDB) ID: 1O6Y [23]). The search model was modified by
truncating side chains that differed in sequence from the S. aureus
protein, and by removing loops and bound ligands. Molecular
replacement yielded one solution containing six copies that gave
rise to a sensible crystal packing. The initial model was then
improved through alternating steps of model building in Coot [29]
and refinement in Phenix [30]. The refinement parameters
included simulated annealing, Ramachandran refinement, and
non-crystallographic symmetry (NCS) restraints. Eight groups per
chain were defined in the NCS refinement, excluding the most
flexible loops. The fragments of chains A, B and C, which were
similar to each other, were defined as NCS-linked groups, and the
same was done for chains D, E and F. Electron density for AMP-
PNP appeared in all six chains during the course of the refinement,
allowing the incorporation of the ligand into the model. The final
structure has good quality, with Rwork and Rfree values [31] of
21.49 and 24.64%, respectively. Geometric restraints for the
AMP-PNP ligand were calculated using the PRODRG server
[32]. Data and refinement statistics are given in Table 1. Atomic
coordinates und structure factors have been deposited in the PDB
(http://www.pdb.org) under the accession code 4EQM.
Figure 3. Overall structure of PknBSA-KD in complex with AMP-PNP. The two views differ by a rotation of 45u around a vertical axis. The AMP-
PNP ligand is located in the cleft between the N- and the C-lobe. Due to its high flexibility, the terminal phosphate group of AMP-PNP is not visible in
the electron density and is therefore not shown here.
doi:10.1371/journal.pone.0039136.g003
Structure of S. aureus PknB
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Activity assay
The functional activity of the kinase domain of S. aureus PknB
(PknBSA-KD) was tested by an in vitro phosphorylation assay.
PknBSA-KD is able to phosphorylate other proteins such as myelin
basic protein (MBP) in an efficient manner (Fig. 2A). The target
protein MBP was previously used as a surrogate substrate for
activity tests of the full-length PknB [12] and of Mycobacterium
tuberculosis PknB [33]. Additionally, PknBSA-KD is able to perform
autophosphorylation (Fig. 2B).
Overall Structure
PknBSA-KD exhibits the typical kinase fold, with N- and C-lobes
creating a central ligand binding region that serves to accommo-
date the substrate or its analog AMP-PNP (Fig. 3). The N-lobe
comprises residues 1 to 90 and contains a six-stranded, antiparallel
b-sheet (strands b0-b5) that packs against the aC-helix. The C-
lobe is composed of six a-helices and a small two-stranded b-sheet
(strands b7-b8). Many kinases contain two additional strands, b6
and b9, which form a second b-sheet in the C-lobe. This small
sheet is absent in PknBSA-KD due to the conformation of the
activation segment (Fig. 4). The two lobes in PknBSA-KD are
connected via the linker region (residues 87–92) and via a loop that
leads from the C-terminus of the aC-helix to the b4 strand
(Fig. 3A, B). Although present in the crystallized PknBSA-KD,
residues 284 to 291 at the C-terminus are not well defined by
electron density and could not be built. We conclude that the
kinase domain of S. aureus PknB includes residues 1–282 (Fig. 1), in
contrast to the computer aided residue assignment for the kinase
region in Donat et. al, 2009 [12] (residues 10–268) and the longer
PknBSA-KD sequence used for crystallization. As is the case in
many kinase structures, high flexibility of the activation loop
(residues 160–171) results in this segment not being traceable in
the electron density maps. The six PknBSA-KD structures present in
the asymmetric unit (molecules A to F, respectively) differ in
several surface-exposed loops as a result of non-identical crystal
contacts. The molecules can be divided into two homogeneous
groups; molecules A, B and C bind benzamidine in a similar
location and form similar crystal contacts. However, these features
are not conserved in molecules D, E and F. The electron density
for molecules A, B and C is more detailed in most regions,
allowing unambiguous assignment of most side chains orienta-
tions. By contrast, the electron density for chains D, E and F is less
well defined, and the density for the ATP-binding site is also
somewhat different in these three chains. The b-phosphates of
AMP-PNP are arranged in a different orientation in chains D-F
compared with chains A-C. The main chain B-factor plot (Fig. S2)
shows overall agreement of the B-factor distribution in all six
chains. Residues forming a secondary structure element have
significantly lower B-factors compared to residues in flexible loop
regions. This flexibility is also reflected in the high overall B-factor.
The B-factor differences between the chains A, B and C are small,
the same is true for chains D, E and F. It is likely that variation in
PknBSA-KD phosphorylation contribute to the observed differences
in electron density. Unless specified otherwise, molecule A will be
used to discuss the salient features of PknBSA-KD.
AMP-PNP binding
The ATP analog AMP-PNP is bound in the cleft separating the
two lobes of the kinase (Fig. 3). The adenine ring projects deep
inside the cleft, into a pocket that is largely hydrophobic. Two
hydrogen bonds, contributed by the backbone amide of Ile90 and
the backbone oxygen of Glu88, anchor the adenine ring (Fig. S3).
The ribose and phosphate moieties of AMP-PNP do not make
equivalent contacts in the different chains, and these contacts are
therefore probably not significant. Furthermore, the c-phosphate
group is not visible in the electron density maps, suggesting that
the lack of contacts with PknBSA-KD increases its flexibility.
PknBSA-KD is in an inactive conformation
In order to determine whether the structure of PknBSA-KD is in
an active or an inactive conformation, we have compared it with
the following kinase structures: (i) PknB of M. tuberculosis, which is
the first reported structure of a bacterial STK (PDB ID: 1O6Y
[23] and 1MRU [24]; (ii) cAMP-dependent protein kinase A
(PKA) in an open conformation (PDB ID: 1CTP [34]); (iii) a closed,
active PKA structure with bound ATP (PDB ID: 1ATP [35]); and
(iv) human c-Src, a tyrosine kinase in the autoinhibited confor-
mation (PDB ID: 2SRC [36]). A structure-based sequence
alignment was generated for all five kinases using ClustalW [37],
Espript [38], Strap [39] (Fig. 5), and superpositions were
performed by aligning residues 100–250 of the C-lobe of
PknBSA-KD with the other structures. Although there is no crystal
structure available for it, we also included the sequence of the B.
subtilis protein kinase C (PrkC) in our analysis because of its
Figure 4. Stereo views of the activation site of PknBSA-KD. (A).
The PknB structure is shown in light orange. It was superimposed onto
the kinase structures of active PKA (grey, PDB ID: 1ATP [35]) and inactive
c-Src (purple, PDB ID: 2SRC [36]) using C-lobe residues 100–250. The
highly conserved residues Lys39, Glu58, Asp151 and Phe152 of PknBSA-
KD are highlighted as red sticks. The latter two residues are part of the
DFG-motif. Corresponding residues Lys72, Glu91, Asp184 and Phe185 of
PKA, as well as the backbone of PKA and ATP, are colored in grey.
Corresponding residues Lys295, Glu310, Asp404 and Phe405 of c-Src, as
well as the backbone of c-Src and ATP, are colored in purple. Mn
2+ ions
in the PKA structure are shown as small gray spheres. (B). Close-up view
of the b-sheet formed by b6 and b9 in active kinases such as PKA. The
colors are the same as in A. The b-sheet in PKA is represented with
triangles as the b-strands only consist of two residues each. The red part
of PknBSA-KD represents residues Ile129, Val130, Lys156 and Ala157,
which are the residues that would form strands b6 and b9 in the active
protein.
doi:10.1371/journal.pone.0039136.g004
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fact that both kinases have three extracellular PASTA domains.
Our analysis highlights several highly conserved residues that
are important for kinase function: the glycine-rich loop, the DFG-
motif, the position of the aC-helix, and the catalytic and
regulatory spines (C-spine and R-spine, respectively). Representa-
tive Fobs-Fcalc omit electron density maps of the ATP binding
regions in chains A and D are shown in Figs. S3A and S3B,
respectively. Fobs-Fcalc omit electron density maps of the DFG-
motif and the inhibition helix of chain A, the AMP-PNP and its
surroundings, and the aF-helix of chains A and D are shown in
Fig. S4A–D. The glycine-rich loop positions the c-phosphate of
ATP in an orientation that facilitates phosphoryl transfer during
catalysis [40]. The DFG-motif is near the activation segment
(Fig. 3). The C- and R-spines are sets of non-contiguous
hydrophobic residues that line the interior of a kinase and stabilize
its active, closed conformation (Fig. 6A, B) [40,41,42,43].
a. Stabilization of the phosphates. Connecting strands b1
and b2 in the N-lobe, the glycine-rich loop has a consensus
sequence of GX1GX2wGX3V, with w denoting a hydrophobic
residue (usually tyrosine or phenylalanine) and X indicating any
amino acid [23,44,45]. Since it serves to stabilize the phosphates of
ATP, this loop is also sometimes referred to as phosphate binding
loop or P-loop [45]. In the active state of kinases, the glycine-rich
loop faces the terminal phosphates of ATP, positioning the c-
phosphate for the transfer reaction [46,47,48]. In contrast, the
glycine-rich loop faces away from ATP in open and inactive
kinases such as PKA (in PDB ID: 1CTP [34]) (Figs. S3, S5). While
the glycine-rich loop is strictly conserved in PKA, c-Src, and many
other kinases, its consensus sequence is altered to
GX1GGMX2X3V in PknBSA-KD and the two other bacterial
kinases included in our comparison. Moreover, the X1 residue is
also a glycine in both B. subtilis PrkC and PknBSA-KD. The
increased number of directly linked glycines would likely render
the loop more flexible in both proteins. The comparison of the
structures shows that the glycine-rich loop in PknBSA-KD is in
a conformation that differs from those observed in both active and
inactive kinases (see above) (Figs. S3, S5). Its ‘‘tip’’ (residues 18 to
20) is twisted upwards, facing away from the phosphates.
However, its ‘‘base’’ (residues 22–25) is still in a position similar
to those observed in active kinases.
In active kinases, the phosphates of ATP are stabilized in the
cleft between the two lobes. The motif involved in binding
phosphates on the C-lobe side is the DFG-motif. Protein kinases
Figure 5. Structure-based sequence alignment. Structure-based sequence alignment of the S. aureus PknB kinase domain with the kinase
domains of B. subtilis PrkC (no structure available), M. tuberculosis PknB (PDB ID: 1MRU [24]), murine cAMP dependent Protein Kinase A (PDB ID: 1ATP
[35]; PDB ID: 1CTP [34]) and human tyrosine protein kinase c-Src (PDB ID: 2SRC [36]). The secondary structure of PknBSA-KD is shown above the
alignment and the numbering of the sequences corresponds to S. aureus as well. The HRD- and DFG-motifs and the glycine-rich loop are underlined
in blue. The highly conserved residues Lys39 and Glu58 are marked in orange. Green triangles indicate the residues of the C-spine; magenta stars
mark residues of the R-spine.
doi:10.1371/journal.pone.0039136.g005
Structure of S. aureus PknB
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which in turn are ligated to an aspartic acid in the DFG-motif
(residues 151–153 in PknBSA-KD). In active kinases, the DFG-motif
also features an internal hydrogen bond between the aspartic acid
and the glycine, and a second hydrogen bond between the glycine
and the amide nitrogen of residue DFG+2 (Ala155 in PknBSA-KD)
[41]. The DFG-motif of PknBSA-KD lacks internal hydrogen
bonds, and no magnesium ion is visible in the vicinity of Asp151. It
is clearly not in an active conformation and does not stabilize the
phosphate groups of AMP-PNP.
A salt bridge is located close to the DFG-motif in active kinases.
To enable an active kinase conformation, the aC-helix must be
oriented such that a salt bridge between the strictly conserved
residues Glu58 and Lys39 can be formed. Lys39 lies in the b3-
strand of the N-lobe and helps to stabilize the a- and b-phosphates
of ATP [46,47,48]. Structural comparison with other active
kinases shows that the aC-helix of PknBSA-KD is not in a closed
conformation (Fig. 4 and Fig. S4B). The helix is rotated away from
the active site, and Glu58 does not form a salt bridge with Lys39.
b. The C- and R-spines. These spines stabilize the active,
closed conformation of a kinase and contain residues from both
lobes of the kinase. The C-spine attaches the active site to the aF-
helix, connecting the two lobes via the adenine ring system. It lines
the rear of the adenosine-binding pocket and stabilizes the closed,
active conformation of protein kinases. In PknBSA-KD, the C-spine
is formed by residues Val24, Ala37 in the N-lobe and residues
Ile139, Leu140, Ile141, Leu95, Val198 and Met202 in the C-lobe
(Fig. 6A, C). The C-spine of PknBSA-KD and the bound adenine
ring superimpose well with those of the closed, active PKA
structure (Fig. 6C).
The R-spine also serves to stabilize the active conformation of
protein kinases [40,41,42,43]. In PknBSA-KD, the putative residues
for the spine are Met73, Ser62, His131 and Phe152. The latter
residue is part of the DFG-motif. Asp191 is stabilizing the
backbone of His131, thereby anchoring the spine to the aF-helix.
Ser62 lies in the aC-helix and is located four residues C-terminal
to the highly conserved Glu58. Since the DFG-motif and the aC-
helix are not in an active conformation, the R-spine cannot be
fully formed in PknBSA-KD (Fig. 6B, D).
c. Inhibition helix. In order to assume an active state, the
aC-helix of PknBSA-KD would have to change its position (Fig. 4).
This is however not possible in our structure because the space
into which the aC-helix would have to rotate is already occupied
by the activation segment located directly after the DFG-motif
(Fig. 4). In active kinases the activation loop makes close contacts
to the C-lobe [40] and forms the b-sheet between strands b6 and
b9 (Fig. 4B). The activation segment of PknBSA-KD interacts with
the N-lobe and the aC-helix. The activation segment forms a short
helix directly after the DFG-motif and blocks the area for the aC-
helix to assume an active conformation. The putative residues of
b9 are part of the inhibition helix and far away from b6, so that
the b-sheet cannot be formed. The absence of the b6/b9 sheet is
also a marker for an inactive conformation of PknBSA-KD (Fig. 4B).
The PknBSA-KD aC-helix is stabilized by a hydrophobic interface
similar to the one found in the structures of CDK2 and c-Src in
their autoinhibited conformations [36,49,50]. The interface is
formed by several residues in the aC-helix, strands b3 and b4, and
the activation segment.
Analysis of surface conservation
In order to identify conserved features and compare them with
homologous proteins, the PknBSA-KD sequence was aligned with
Figure 6. The C- and R-spine regions of PknBSA-KD. (A, B).
Overview of the location of the two spines in PknBSA-KD. The C-spine is
colored in green, the R-spine in the background in blue. The two views
differ by the indicated rotation to provide a better view of the
orientation and location of the R-spine. (C). Detailed view of the
residues belonging to the C-spine of PknBSA-KD and the adenine of
AMP-PNP as part of the spine are shown in green. The residues of the C-
spine of PKA in a closed state (PDB ID: 1ATP [35]) are shown for
comparison. (D). Detailed view of the R-spine residues of PknBSA-KD in
blue. Corresponding residues of PKA are shown in grey. While the spine
is formed in PKA, it is interrupted by the Ser62 and placed away from
ideal position in PknBSA-KD. The structure of PKA in panels C and D was
aligned with PknBSA-KD C-lobe residues 100–250.
doi:10.1371/journal.pone.0039136.g006
Figure 7. Analysis of conservation of PknB residues. Surface
representation of PknBSA-KD. The three views differ by rotations of 120u
and 240u, respectively, around a vertical axis. The coloring is based on
an alignment of 24 bacterial STKs (Fig. S6). Blue indicates highly
conserved residues (100–91% conservation in dark blue, 87–70%
conservation in blue, and 66–54% light blue). Residues that are highly
conserved in most kinases but are different in PknBSA-KD are colored in
orange (83–70% conservation in orange, 66–54% conservation in light
orange). In the right panel, the benzamidine bound to PknBSA-KD in
three of the six chains of the asymmetric unit is shown as a stick model.
The benzamidine is not visible in the other two panels.
doi:10.1371/journal.pone.0039136.g007
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analysis, we selected the bacterial STKs recently analyzed by
Pereira et al. [10]. All analyzed kinases exhibit strong conservation
in the prototypical regions required for catalytic function, such as
the DFG-, HRD- and SPE-motifs and the glycine-rich loop. In
order to depict the location and distribution of conserved residues,
we mapped them onto the surface of PknBSA-KD (Fig. 7). As
expected, residues important for the catalytic function of the
kinase are highly conserved (highlighted blue in Fig. 7). These
residues cluster in the ATP-binding site, the glycine-rich loop, and
the DFG-, HRD- and SPE-motifs. However, a small number of
residues are highly conserved in most other kinases but differ from
the consensus sequence in PknB (highlighted orange in Fig. 7). The
remaining surface of PknBSA-KD is remarkably devoid of
conserved residues.
Discussion
We report here the crystal structure of the catalytically
competent kinase region of S. aureus PknB. In its physiological
context, the kinase is attached to the bacterial cell wall via
a membrane anchor, and it phosphorylates substrates in response
to stimuli that engage the extracellular PASTA domains. Activity
assays demonstrate that purified PknBSA-KD is able to phosphor-
ylate substrates efficiently. However, an analysis of structural
parameters that define the active states of protein kinases clearly
demonstrates that PknBSA-KD has crystallized in an inactive
conformation. Although it does bind the ATP analog AMP-PNP,
this substrate is not bound in a conformation that would enable
catalysis. The AMP-PNP triphosphate moiety is not contacted by
either a magnesium ion or residues from the glycine-rich loop or
the DFG-motif. As PknBSA-KD is catalytically active in solution, it
is conceivable that it exists in different conformations, correspond-
ing to active and inactive states, in solution, perhaps owing to
different states of phosphorylation. Hence, crystallization likely
selected the inactive state.
Dimer formation
An attractive scenario for PknB activation could be based on
dimer formation, and dimerization has in fact been implicated in
the regulation of the activity of the M. tuberculosis PknB kinase
domain. In that case, the kinase domain forms dimers that are
stabilized by a salt bridge between Arg9 in one monomer and
Asp75 of another monomer [22,51]. Although PknBSA-KD
consistently eluted as a monomer in gel filtration experiments in
solution (Fig. S1A), it is conceivable that low-affinity dimerization
of PknBSA-KD could occur at higher concentration. This hypoth-
esis was evaluated by chemical crosslinking experiments using
glutaraldehyde (Fig. S7). No crosslinked dimer of PknBSA-KD was
obtained under any of the tested conditions, while a control
protein known to form trimers could be successfully cross-linked
under identical conditions. Additionally, inspection of the crystal
packing can sometimes provide clues about the possible existence
of oligomers. We find that three of the six PknBSA-KD molecules
present in the crystals form nearly identical dimers with their
symmetry mates (A–C9, B–B9, C–A9), and the arrangement of
these putative dimers resembles the M. tuberculosis PknB dimer
(Fig. 8). It is therefore conceivable that activation of S. aureus PknB
also involves dimerization. We note, however, that the putative
PknBSA-KD dimer interface contains benzamidine, a compound
that was present in the crystallization solution and that was
required to obtain good-quality crystals. The observed dimer may
therefore be a crystallization artifact. Moreover, the three
remaining molecules in the crystals (chains D, E, F) do not form
similar dimers.
It is of course possible that dimerization of the kinase region is
linked to its phosphorylation status, and that the copies of PknBSA-
KD present in the crystals have different states of phosphorylation,
thus impacting their dimerization properties.
Another, perhaps more likely, scenario could link dimerization
to the extracellular PASTA domains, which could alter their
association state in response to signal binding [11,17].
Inhibition helix
Although it represents an inactive conformation of the kinase,
the PknBSA-KD crystal structure nevertheless provides insights into
a pathway of activation. In order to activate PknBSA-KD, the aC-
helix would need to significantly change its location by rotating
into the binding site. Such a rotation, however, is not possible in
our crystal structure because the space that would accommodate
the rotated aC-helix is already occupied by the activation segment,
which forms a short helix directly following the DFG-motif (Fig. 4
and Fig. S4A). The activation loop of active kinases makes close
contacts with the C-lobe, whereas in PknBSA-KD it interacts with
the N-lobe and the aC-helix.
Figure 8. Analysis of PknBSA-KD crystal contacts. (A). Footprint of
contacts between a symmetry mate of molecule C (C9) and molecule A
in the crystals. Molecule A is shown in surface representation. Areas
within black lines indicate crystal contacts with molecule C9 (distance
,4.5 A ˚). Areas within yellow lines indicate the residues involved in
dimer formation [22]. The surface conservation is shown as in Fig. 7,
and the benzamidine is bound to chain A of PknBSA-KD is shown as a red
stick model. Molecule pairs B/B9 and C9/A form similar crystal contacts.
(B). Detailed view into the dimer interface formed by the A/C9 dimer.
Chains A and C9 of PknBSA-KD are shown in orange and yellow,
respectively. Chains A and B of dimeric M. tuberculosis PknB (PDB ID:
1MRU [24]) are in grey. Residues Arg9, Tyr10, Leu32 and Asp75, which
are involved in dimer formation, are represented with sticks. These
residues were also used for superimposing the two dimers. (C).
Overview of the orientation of the dimer of M. tuberculosis PknB and
PknBSA-KD. The colors are the same as in panel B. The N-lobes of PknBSA-
KD chain A and M. tuberculosis PknB chain A were superposed. (D).
Crystal contact involving chains D and E in PknBSA-KD. The orientation of
chain D is the same as that of chain A in panel C.
doi:10.1371/journal.pone.0039136.g008
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the formation of an active PknB conformation. This could be
triggered by autophosphorylation in the activation segment.
Thr164 could play a key role in this conformational change.
Structural alignments with inactive c-Src kinase reveal a similar
orientation of the activation segment, with an autoinhibition helix
blocking the inward rotation of the aC-helix [36,52] (Fig. 4). In
this case, c-Src can be activated through the phosphorylation of
residue Tyr416, which is the residue equivalent to Thr164 in
PknB.
A dissolving of the inactive state of the activation segment could
conceivably trigger a downward movement of the glycine-rich
loop to stabilize the b- and c-phosphates of the ATP. Due to weak
electron density as a result of flexibility, it is not possible to model
the activation segment. However, difference electron density in
this region suggests that parts of the activation loop lie next to the
glycine-rich loop, preventing interaction of the glycine-rich loop
with phosphates.
In conclusion, our structural study provides improved un-
derstanding of the function of eukaryotic like serine/threonine
kinases in bacteria at the molecular level. Future work will aim at
the identification of substrates of PknB, the molecular mechanisms
of substrate selection and the role of autophosphorylation for the
activity of the kinase. In particular, the role of ligand-dependent
dimerization of extracellular PASTA domains for activation of
PknB remains to be clarified. Moreover, recent work provided
evidence that PknB is embedded in the tight regulatory network
controlling virulence of S. aureus. The structural information
presented in this study may serve as a basis for further
investigations of the molecular mechanisms determining patho-
genesis of the major human pathogen S. aureus.
Supporting Information
Figure S1 Biochemical and biophysical analysis of
purified PknBSA-KD. A. Size-exclusion chromatography run
on Superdex 75 (PC 3.2/30). The elution profile of PknBSA-KD is
shown in red in comparison to standard proteins. B. SDS-PAGE
of purified PknBSA-KD. C. CD-spectrum of purified PknBSA-KD.
(TIF)
Figure S2 B-factor plot for the six chains of PknBSA-KD
present in the asymmetric unit. Secondary structure
elements are aligned below the plot, with a-helices colored in
blue and b-strands colored in orange. The red line indicates the
overall B-factor average for all six chains.
(TIF)
Figure S3 Stereo view into the AMP-PNP binding site.
The depicted map is an omit map (Fobs-Fcalc) of the ligand,
contoured at 3.0 s and drawn with a radius of 5A ˚ around AMP-
PNP. Panels A and B show omit maps of the AMP-PNP bound to
chains A and D, respectively.
(TIF)
Figure S4 Stereo views of representative omit maps of
PknBSA-KD. All panels show Fobs-Fcalc omit electron density maps
contoured at 1.0 s. In panel A the omit map for the DFG-motif
and the inhibition helix is shown. Panel B shows the phosphate
binding region. Panels C and D show the omit map for the aF-
helix for chain A in panel C and chain D in panel D. Maps were
drawn with radii of 3A ˚ (panels A, C and D) and 8A ˚ (panel B)
around the depicted coordinates. The larger radius for panel B
was chosen to show that no extra density that would account for
a magnesium ion exists in the vicinity of the AMP-PNP ligand.
(TIF)
Figure S5 Orientation of the glycine-rich loop. All kinases
were aligned with the C-lobe of PknBSA-KD (residues 100–250).
The PknBSA-KD structure is drawn in orange. The closed PKA
structure is shown in green (PDB ID: 1ATP [35]), and the open
PKA structure is shown in red (PDB ID: 1CTP [34]). The kinase
domain of c-Src (PDB ID: 2SRC [36]) is shown in purple.
(TIF)
Figure S6 Alignment of selected kinases and analysis of
conservation. The kinases were selected according to [10]. Five
kinases were omitted due to lack of DFG-, SPE-, HRD-motif or
the N-lobe. The color code is identical to that used in Fig 7. Blue
indicates highly conserved residues (100–91% conservation in dark
blue 88–74% in blue and 69–54% light blue). Residues highly
conserved but different in PknBSA-KD are colored in orange (88–
71% in orange, 69–54% in light orange). The selected kinases are
(Uniprot-ID in parentheses): Staphylococcus aureus, PknB (Q7A5Z8);
Bacillus subtilis, PrkC (O34507); Corynebacterium glutamicum, PknA
(Q8NU97); Corynebacterium glutamicum, PknB (Q8NU98); Corynebac-
terium glutamicum, PknG (Q6M299); Corynebacterium glutamicum, PknL
(Q6M3Q8); Mycobacterium tuberculosis, PknA (P65726); Mycobacterium
tuberculosis, PknB (P0A5S4); Mycobacterium tuberculosis, PknD
(O05871); Mycobacterium tuberculosis, PknE (P72003); Mycobacterium
tuberculosis, PknF (P72003); Mycobacterium tuberculosis, PknG
(P65728); Mycobacterium tuberculosis, PknH (Q11053); Mycobacterium
tuberculosis, PknI (P65730); Mycobacterium tuberculosis, PknJ (P65732);
Mycobacterium tuberculosis, PknK (P95078); Mycobacterium tuberculosis,
PknL (O53510); Myxococcus xanthus, Pkn4 (Q95478); Myxococcus
xanthus, Pkn8 (Q9XBP6); Myxococcus xanthus, Pkn14 (Q93NE3);
Pseudomonas aeruginosa, PpkA (Q9I758); Streptococcus pneumonia, StkP
(Q8KY50).
(TIF)
Figure S7 Chemical cross-linking of PknBSA-KD and
controls with glutaraldehyde. Shown is an SDS-PAGE
analysis of the crosslinking experiment. Untreated (ut) protein
was loaded on the gel next to each protein as controls. The small
bands in PknBSA-KD lanes indicate a weak impurity of PknBSA-KD
at 80 kDa.
(TIF)
Acknowledgments
We thank the beam line staff at the Swiss Light Source for assistance with
data collection.
Author Contributions
Conceived and designed the experiments: SR SD KO TS. Performed the
experiments: SR SD. Analyzed the data: SR SD KO TS. Wrote the paper:
SR SD KO TS.
References
1. Klevens RM, Morrison MA, Nadle J, Petit S, Gershman K, et al. (2007) Invasive
methicillin-resistant Staphylococcus aureus infections in the United States. JAMA:
the journal of the American Medical Association 298: 1763–1771.
2. Hansra NK, Shinkai K (2011) Cutaneous community-acquired and hospital-
acquired methicillin-resistant Staphylococcus aureus. Dermatologic therapy 24: 263–
272.
3. Bohach GA, Fast DJ, Nelson RD, Schlievert PM (1990) Staphylococcal and
streptococcal pyrogenic toxins involved in toxic shock syndrome and related
illnesses. Critical reviews in microbiology 17: 251–272.
4. Lowy FD (1998) Staphylococcus aureus infections. The New England journal of
medicine 339: 520–532.
Structure of S. aureus PknB
PLoS ONE | www.plosone.org 8 June 2012 | Volume 7 | Issue 6 | e391365. Deftereos SP, Michailidou E, Karagiannakis GK, Grigoriadi S, Prassopoulos P
(2009) Hematogenous infantile infection presenting as osteomyelitis and septic
arthritis: a case report. Cases journal 2: 8293.
6. Aguilar J, Urday-Cornejo V, Donabedian S, Perri M, Tibbetts R, et al. (2010)
Staphylococcus aureus meningitis: case series and literature review. Medicine 89:
117–125.
7. Otto M (2010) Looking toward basic science for potential drug discovery targets
against community-associated MRSA. Medicinal research reviews 30: 1–22.
8. Hunter T (1995) Protein kinases and phosphatases: the yin and yang of protein
phosphorylation and signaling. Cell 80: 225–236.
9. Kennelly PJ (2002) Protein kinases and protein phosphatases in prokaryotes:
a genomic perspective. FEMS microbiology letters 206: 1–8.
10. Pereira SF, Goss L, Dworkin J (2011) Eukaryote-like serine/threonine kinases
and phosphatases in bacteria. Microbiology and molecular biology reviews:
MMBR 75: 192–212.
11. Ruggiero A, Squeglia F, Marasco D, Marchetti R, Molinaro A, et al. (2011) X-
ray structural studies of the entire extracellular region of the serine/threonine
kinase PrkC from Staphylococcus aureus. The Biochemical journal 435: 33–41.
12. Donat S, Streker K, Schirmeister T, Rakette S, Stehle T, et al. (2009)
Transcriptome and functional analysis of the eukaryotic-type serine/threonine
kinase PknB in Staphylococcus aureus. Journal of bacteriology 191: 4056–4069.
13. Lomas-Lopez R, Paracuellos P, Riberty M, Cozzone AJ, Duclos B (2007)
Several enzymes of the central metabolism are phosphorylated in Staphylococcus
aureus. FEMS microbiology letters 272: 35–42.
14. De Lencastre H, Wu SW, Pinho MG, Ludovice AM, Filipe S, et al. (1999)
Antibiotic resistance as a stress response: complete sequencing of a large number
of chromosomal loci in Staphylococcus aureus strain COL that impact on the
expression of resistance to methicillin. Microbial drug resistance 5: 163–175.
15. Yeats C, Finn RD, Bateman A (2002) The PASTA domain: a beta-lactam-
binding domain. Trends in biochemical sciences 27: 438.
16. Gordon E, Mouz N, Duee E, Dideberg O (2000) The crystal structure of the
penicillin-binding protein 2x from Streptococcus pneumoniae and its acyl-enzyme
form: implication in drug resistance. Journal of molecular biology 299: 477–485.
17. Paracuellos P, Ballandras A, Robert X, Kahn R, Herve M, et al. (2010) The
extended conformation of the 2.9-A crystal structure of the three-PASTA
domain of a Ser/Thr kinase from the human pathogen Staphylococcus aureus.
Journal of molecular biology 404: 847–858.
18. Truong-Bolduc QC, Hooper DC (2010) Phosphorylation of MgrA and its effect
on expression of the NorA and NorB efflux pumps of Staphylococcus aureus. Journal
of bacteriology 192: 2525–2534.
19. Tamber S, Schwartzman J, Cheung AL (2010) Role of PknB kinase in antibiotic
resistance and virulence in community-acquired methicillin-resistant Staphylococ-
cus aureus strain USA300. Infection and immunity 78: 3637–3646.
20. Miller M, Donat S, Rakette S, Stehle T, Kouwen TR, et al. (2010)
Staphylococcal PknB as the first prokaryotic representative of the proline-
directed kinases. PloS one 5: e9057.
21. Debarbouille M, Dramsi S, Dussurget O, Nahori MA, Vaganay E, et al. (2009)
Characterization of a serine/threonine kinase involved in virulence of
Staphylococcus aureus. Journal of bacteriology 191: 4070–4081.
22. Lombana TN, Echols N, Good MC, Thomsen ND, Ng HL, et al. (2010)
Allosteric activation mechanism of the Mycobacterium tuberculosis receptor Ser/Thr
protein kinase, PknB. Structure 18: 1667–1677.
23. Ortiz-Lombardia M, Pompeo F, Boitel B, Alzari PM (2003) Crystal structure of
the catalytic domain of the PknB serine/threonine kinase from Mycobacterium
tuberculosis. The Journal of biological chemistry 278: 13094–13100.
24. Young TA, Delagoutte B, Endrizzi JA, Falick AM, Alber T (2003) Structure of
Mycobacterium tuberculosis PknB supports a universal activation mechanism for
Ser/Thr protein kinases. Nature structural biology 10: 168–174.
25. Mieczkowski C, Iavarone AT, Alber T (2008) Auto-activation mechanism of the
Mycobacterium tuberculosis PknB receptor Ser/Thr kinase. The EMBO journal 27:
3186–3197.
26. Wehenkel A, Fernandez P, Bellinzoni M, Catherinot V, Barilone N, et al. (2006)
The structure of PknB in complex with mitoxantrone, an ATP-competitive
inhibitor, suggests a mode of protein kinase regulation in mycobacteria. FEBS
letters 580: 3018–3022.
27. Kabsch W (2010) Xds. Acta crystallographica Section D, Biological crystallog-
raphy 66: 125–132.
28. McCoy AJ, Grosse-Kunstleve RW, Adams PD, Winn MD, Storoni LC, et al.
(2007) Phaser crystallographic software. Journal of applied crystallography 40:
658–674.
29. Emsley P, Lohkamp B, Scott WG, Cowtan K (2010) Features and development
of Coot. Acta crystallographica Section D, Biological crystallography 66: 486–
501.
30. Adams PD, Afonine PV, Bunkoczi G, Chen VB, Davis IW, et al. (2010)
PHENIX: a comprehensive Python-based system for macromolecular structure
solution. Acta crystallographica Section D, Biological crystallography 66: 213–
221.
31. Brunger AT (1992) Free R value: a novel statistical quantity for assessing the
accuracy of crystal structures. Nature 355: 472–475.
32. Schuttelkopf AW, van Aalten DM (2004) PRODRG: a tool for high-throughput
crystallography of protein-ligand complexes. Acta crystallographica Section D,
Biological crystallography 60: 1355–1363.
33. Av-Gay Y, Jamil S, Drews SJ (1999) Expression and characterization of the
Mycobacterium tuberculosis serine/threonine protein kinase PknB. Infection and
immunity 67: 5676–5682.
34. Karlsson R, Zheng J, Xuong N, Taylor SS, Sowadski JM (1993) Structure of the
mammalian catalytic subunit of cAMP-dependent protein kinase and an
inhibitor peptide displays an open conformation. Acta crystallographica Section
D, Biological crystallography 49: 381–388.
35. Zheng J, Trafny EA, Knighton DR, Xuong NH, Taylor SS, et al. (1993) 2.2 A
refined crystal structure of the catalytic subunit of cAMP-dependent protein
kinase complexed with MnATP and a peptide inhibitor. Acta crystallographica
Section D, Biological crystallography 49: 362–365.
36. Xu W, Doshi A, Lei M, Eck MJ, Harrison SC (1999) Crystal structures of c-Src
reveal features of its autoinhibitory mechanism. Molecular cell 3: 629–638.
37. Thompson JD, Higgins DG, Gibson TJ (1994) CLUSTAL W: improving the
sensitivity of progressive multiple sequence alignment through sequence
weighting, position-specific gap penalties and weight matrix choice. Nucleic
acids research 22: 4673–4680.
38. Gouet P, Courcelle E, Stuart DI, Metoz F (1999) ESPript: analysis of multiple
sequence alignments in PostScript. Bioinformatics 15: 305–308.
39. Gille C, Frommel C (2001) STRAP: editor for STRuctural Alignments of
Proteins. Bioinformatics 17: 377–378.
40. Taylor SS, Kornev AP (2011) Protein kinases: evolution of dynamic regulatory
proteins. Trends in biochemical sciences 36: 65–77.
41. Kornev AP, Haste NM, Taylor SS, Eyck LF (2006) Surface comparison of active
and inactive protein kinases identifies a conserved activation mechanism.
Proceedings of the National Academy of Sciences of the United States of
America 103: 17783–17788.
42. Kornev AP, Taylor SS (2010) Defining the conserved internal architecture of
a protein kinase. Biochimica et biophysica acta 1804: 440–444.
43. Kornev AP, Taylor SS, Ten Eyck LF (2008) A helix scaffold for the assembly of
active protein kinases. Proceedings of the National Academy of Sciences of the
United States of America 105: 14377–14382.
44. Bossemeyer D (1994) The glycine-rich sequence of protein kinases: a multifunc-
tional element. Trends in biochemical sciences 19: 201–205.
45. Saraste M, Sibbald PR, Wittinghofer A (1990) The P-loop–a common motif in
ATP- and GTP-binding proteins. Trends in biochemical sciences 15: 430–434.
46. Huse M, Kuriyan J (2002) The conformational plasticity of protein kinases. Cell
109: 275–282.
47. Cox S, Radzio-Andzelm E, Taylor SS (1994) Domain movements in protein
kinases. Current opinion in structural biology 4: 893–901.
48. Johnson LN, Noble ME, Owen DJ (1996) Active and inactive protein kinases:
structural basis for regulation. Cell 85: 149–158.
49. Hubbard SR (1999) Src autoinhibition: let us count the ways. Nature structural
biology 6: 711–714.
50. Jeffrey PD, Russo AA, Polyak K, Gibbs E, Hurwitz J, et al. (1995) Mechanism of
CDK activation revealed by the structure of a cyclinA-CDK2 complex. Nature
376: 313–320.
51. Alber T (2009) Signaling mechanisms of the Mycobacterium tuberculosis receptor
Ser/Thr protein kinases. Current opinion in structural biology 19: 650–657.
52. Schulze-Gahmen U, De Bondt HL, Kim SH (1996) High-resolution crystal
structures of human cyclin-dependent kinase 2 with and without ATP: bound
waters and natural ligand as guides for inhibitor design. Journal of medicinal
chemistry 39: 4540–4546.
Structure of S. aureus PknB
PLoS ONE | www.plosone.org 9 June 2012 | Volume 7 | Issue 6 | e39136